Hologic Inc (BSP:H1OL34)
R$ 447.04 0 (0%) Market Cap: 101.45 Bil Enterprise Value: 103.43 Bil PE Ratio: 22.62 PB Ratio: 3.40 GF Score: 86/100

Hologic Inc at JPMorgan US All-Stars Conference (Virtual) Transcript

Sep 16, 2020 / 04:00PM GMT
Release Date Price: R$327.02
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. I think we're good to go. Thank you, everybody, for joining us today. We've got the management team from Hologic. We've got Steve, Karleen and Mike with us. So welcome to you all. (Operator Instructions)

Questions & Answers

Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

I thought, Steve, I'd start out with the guidance update you provided last week. And you're talking about better revenues, obviously. I'm wondering if you could just talk a little bit about what's embedded here by segment. I think, previously, you've been talking about COVID demand increasing sequentially. Diagnostics as a whole, potentially doubling. Can you just maybe give us a little bit more of the nuances behind the increased guidance?

Stephen P. MacMillan
Hologic, Inc. - Chairman, CEO & President

Yes, sure, Tycho. I think, obviously, you picked it up, and it's a pretty good-sized beat that we feel like is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot